The glucose-insulin-potassium (GIK) regimen in the treatment of myocardial ischemia.
D000200:Action Potentials; D000255:Adenosine Triphosphate / Q000378:metabolism; D004562:Electrocardiography; D005947:Glucose / Q000008:administration & dosage / Q000378:metabolism / Q000627:therapeutic use*; D006019:Glycolysis; D006321:Heart / Q000502:physiology; D006801:Humans; D007275:Injections, Intravenous; D007328:Insulin / Q000008:administration & dosage / Q000502:physiology / Q000627:therapeutic use*; D009203:Myocardial Infarction / Q000188:drug therapy* / Q000378:metabolism / Q000401:mortality; D009206:Myocardium / Q000378:metabolism; D010101:Oxygen Consumption; D010710:Phosphates / Q000378:metabolism; D011188:Potassium / Q000378:metabolism; D011189:Potassium Chloride / Q000008:administration & dosage / Q000627:therapeutic use*; D014481:United States
D007328:Insulin; D010710:Phosphates; D011189:Potassium Chloride; D000255:Adenosine Triphosphate; D005947:Glucose; D011188:Potassium